Personal information

Activities

Employment (6)

Newcastle University: Newcastle upon Tyne, Newcastle upon Tyne, GB

2022-08 to present | Professor of Immunotherapy (Translational & Clinical Research Institute)
Employment
Source: Self-asserted source
Catharien Hilkens

Newcastle University: Newcastle upon Tyne, Tyne and Wear, GB

2003-10-15 to present | Professor of Immunotherapy (Translational and Clinical Research)
Employment
Source: check_circle
Newcastle University via ORCID Member Portal

Newcastle University: Newcastle upon Tyne, GB

2009 to 2022-08 | Reader in Immunotherapy (Translational & Clinical Research Institute)
Employment
Source: Self-asserted source
Catharien Hilkens

Newcastle University: Newcastle upon Tyne, Newcastle upon Tyne, GB

2003-10 to 2009 | Lecturer (Institute of Cellular Medicine)
Employment
Source: Self-asserted source
Catharien Hilkens

Cancer Research UK: London, London, GB

1998 to 2003-10 | Post-doc
Employment
Source: Self-asserted source
Catharien Hilkens

Universiteit van Amsterdam: Amsterdam, Noord-Holland, NL

1997 to 1998 | Post-doc
Employment
Source: Self-asserted source
Catharien Hilkens

Education and qualifications (2)

Universiteit van Amsterdam: Amsterdam, Noord-Holland, NL

1991-11-20 to 1997-01-27 | PhD (Academic Medical Centre)
Education
Source: Self-asserted source
Catharien Hilkens

Universiteit Leiden: Leiden, Zuid-Holland, NL

1986-10 to 1991-11-19 | Drs (equivalent to Masters)
Education
Source: Self-asserted source
Catharien Hilkens

Professional activities (3)

British Society for Immunology: London, GB

full member
Membership
Source: Self-asserted source
Catharien Hilkens

University of Glasgow: Glasgow, GB

2014-08-01 to present | Honorary Senior Lecturer (Institute of Infection, Immunity & Inflammation)
Invited position
Source: Self-asserted source
Catharien Hilkens

University of Birmingham: Birmingham, GB

2014-08-01 to 2017-07-31 | Honorary Research Fellow (School of Immunity and Infection)
Invited position
Source: Self-asserted source
Catharien Hilkens

Funding (13)

INsTRuCT: Innovative Training in Regulatory Cell Therapy

2019-12 to 2023-12 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER:

86003

Source: Self-asserted source
Catharien Hilkens

A novel engineered drug delivery system to effectively generate tolerogenic dendritic cells in vivo

2019-08 to 2020-01 | Award
Northern Accelerator (Newcastle upon Tyne, GB)
GRANT_NUMBER:

KH191771

Source: Self-asserted source
Catharien Hilkens

Prototype hydrogels for immunomodulatory applications

2019-05 to 2019-08 | Grant
Medical Research Council (Swindon, GB)
GRANT_NUMBER:

BH190870

Source: Self-asserted source
Catharien Hilkens

Arthritis Research UK RACE Centre of Excellence

2019-04 to 2025-03 | Award
Arthritis Research UK (Chesterfield, GB)
GRANT_NUMBER:

22072

Source: Self-asserted source
Catharien Hilkens

Mapping the road to immune peripheral immune tolerance

2018-10 to 2023-09 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
Source: Self-asserted source
Catharien Hilkens

Mapping physiology to function: an experimental medicine study of autologous tolerogenic dendritic cell therapy for rheumatoid arthritis, with a focus on route of delivery (AuToDeCRA 2)

2018-08-20 to 2022-08-19 | Grant
British Heart Foundation (London, GB)
GRANT_NUMBER:

BHF-21811

Source: Self-asserted source
Catharien Hilkens via DimensionsWizard

Monitoring migration of tolerogenic dendritic cells by 19F-Magnetic Resonance Imaging - validation of 19F-labelling.

2017-11 to 2018-04 | Award
Medical Research Council (London, GB)
Source: Self-asserted source
Catharien Hilkens

Where, when and what do tolerogenic dendritic cells do to T cells?

2017-10-01 to 2021-09-30 | Grant
Arthritis Research UK (Chesterfield, GB)
GRANT_NUMBER:

ARUK-21570

Source: Self-asserted source
Catharien Hilkens via DimensionsWizard

Rheuma Tolerance for Cure (RTCure)

2017-09 to 2021-08 | Grant
Innovative Medicines Initiative (Brussels, BE)
Source: Self-asserted source
Catharien Hilkens

MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)

2017-03-31 to 2021-03-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/N026977/1
Source: Self-asserted source
Catharien Hilkens via DimensionsWizard

Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis

2016-05-05 to 2018-05-04 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 654882
Source: Self-asserted source
Catharien Hilkens via DimensionsWizard

Do synovial dendritic cells contribute to the pathogenesis of inflammatory arthritis?

2015-11 to 2017-10 | Grant
JGW Patterson Foundation (Newcastle upon Tyne, GB)
Source: Self-asserted source
Catharien Hilkens

Rheumatoid Arthritis Centre of Excellence (RACE) - Towards a Cure.

2013-01-01 to 2017-12-31 | Grant
Arthritis Research UK (Chesterfield, GB)
GRANT_NUMBER:

ARUK-20298

Source: Self-asserted source
Catharien Hilkens via DimensionsWizard